Home › NDC Lookup › RxCUI directory › RxCUI 1236716

Chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet [Stah... — RxCUI 1236716

RxNorm drug concept · Semantic branded drug
RxCUI 1236716 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1236716
Official nameChlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet [Stahist AD]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asStahist AD 25 MG / 60 MG Oral Tablet
FDA products mapped1
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pseudoephedrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Pseudoephedrine is a decongestant — it works to temporarily shrink the swollen blood vessels inside your nasal passages and sinuses, which helps open things up so you can breathe m...
  • What exactly does pseudoephedrine do for my congestion?
  • Yes, it does. The regular tablets and Zephrex D capsules are taken every 4 to 6 hours, while extended-release tablets like Sudafed Sinus Congestion 12 Hour or Good Sense Suphedrine...
  • Does it matter which product or form I pick?
📖 Read our full Pseudoephedrine guide →

🕸️ Concept Web — How Chlorcyclizine hydrochloride 25 MG / pseudoephed... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet [Stahist AD] RxCUI 1236716

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Chlorcyclizine 2354
    • Pseudoephedrine 8896
    • Chlorcyclizine / pseudoephedrine 815844
    • Chlorcyclizine hydrochloride 235725
    • Pseudoephedrine hydrochloride 91168
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Stahist AD 1236711
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Chlorcyclizine / pseudoephedrine Oral Tablet 371388
    • Chlorcyclizine hydrochloride / pseudoephedrine hydrochloride Oral Tablet 2646777
    • Chlorcyclizine / pseudoephedrine Oral Product 1161870
    • Chlorcyclizine / pseudoephedrine Pill 1161871
    • Chlorcyclizine hydrochloride / pseudoephedrine hydrochloride Oral Product 2662104
    • Chlorcyclizine hydrochloride / pseudoephedrine hydrochloride Pill 2660321
    • Chlorcyclizine / pseudoephedrine Oral Tablet [Stahist AD] 1236713
    • Chlorcyclizine hydrochloride / pseudoephedrine hydrochloride Oral Tablet [Stahist AD] 2657484
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet SCD · 1235861
  • Chlorcyclizine hydrochloride 25 MG SCDC · 1190296
  • Pseudoephedrine hydrochloride 60 MG SCDC · 996721
  • Chlorcyclizine / pseudoephedrine Oral Tablet SCDF · 371388
  • Chlorcyclizine hydrochloride / pseudoephedrine hydrochloride Oral Tablet SCDFP · 2646777
  • Chlorcyclizine / pseudoephedrine Oral Product SCDG · 1161870
  • Chlorcyclizine / pseudoephedrine Pill SCDG · 1161871
  • Chlorcyclizine hydrochloride / pseudoephedrine hydrochloride Oral Product SCDGP · 2662104
  • Chlorcyclizine hydrochloride / pseudoephedrine hydrochloride Pill SCDGP · 2660321

Brand-Name Concepts

  • Chlorcyclizine hydrochloride 25 MG / pseudoephedrine hydrochloride 60 MG [Stahist AD] SBDC · 1236712
  • Chlorcyclizine / pseudoephedrine Oral Tablet [Stahist AD] SBDF · 1236713
  • Chlorcyclizine hydrochloride / pseudoephedrine hydrochloride Oral Tablet [Stahist AD] SBDFP · 2657484
  • Stahist AD Oral Product SBDG · 1236714
  • Stahist AD Pill SBDG · 1236715
  • Stahist AD BN · 1236711

📦 FDA Products & Package NDCs

1 product · 3 package NDCs
3 package NDCs map to RxCUI 1236716 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
58407-0625-01 1 TABLET in 1 BLISTER PACK (58407-625-01) STAHIST AD Magna Pharmaceuticals, Inc. 2019-09-01
58407-0625-06 6 BLISTER PACK in 1 BOX (58407-625-06) / 1 TABLET in 1 BLIS... STAHIST AD Magna Pharmaceuticals, Inc. 2011-12-20
58407-0625-30 1 BOTTLE in 1 BOX (58407-625-30) / 30 TABLET in 1 BOTTLE STAHIST AD Magna Pharmaceuticals, Inc. 2011-12-20
Observed labelers: Magna Pharmaceuticals, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.